Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Fried

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 27, 2005
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis CMark W Russo, Roberto J Firpi, David R Nelson, et al.
The American Journal of Gastroenterology|October 1, 2009
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C studyDonna M Evon, Darmendra Ramcharran, Steven H Belle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis CMark W Russo, Joseph A Galanko, Steven L Zacks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2007
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extractZhiming Wen, Todd E Dumas, Sarah J Schrieber, et al.
Annals of Internal Medicine|March 21, 2017
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic ReviewOluwaseun Falade-Nwulia, Catalina Suarez-Cuervo, David R Nelson, et al.
The Annals of Pharmacotherapy|May 24, 2007
Assessing the validity of self-reported medication adherence in hepatitis C treatmentScott R Smith, Abdus S Wahed, Stephanie S Kelley, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2014
Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potentialJulie C Lauffenburger, Christina L Mayer, Roy L Hawke, et al.
Journal of Clinical Gastroenterology|April 25, 2006
Social stigmatization and hepatitis C virus infectionSteven Zacks, Kimberly Beavers, Dickens Theodore, et al.
The Patient|November 25, 2016
What's Important to the Patient? Informational Needs of Patients Making Decisions About Hepatitis C TreatmentDonna M Evon, Carol E Golin, Teodora Stoica, et al.
Digestive Diseases and Sciences|March 31, 2007
High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbiditiesDonna M Evon, Amit Verma, Karen A Dougherty, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 27, 2005
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis CMark W Russo, Roberto J Firpi, David R Nelson, et al.
The American Journal of Gastroenterology|October 1, 2009
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C studyDonna M Evon, Darmendra Ramcharran, Steven H Belle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis CMark W Russo, Joseph A Galanko, Steven L Zacks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2007
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extractZhiming Wen, Todd E Dumas, Sarah J Schrieber, et al.
Annals of Internal Medicine|March 21, 2017
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic ReviewOluwaseun Falade-Nwulia, Catalina Suarez-Cuervo, David R Nelson, et al.
The Annals of Pharmacotherapy|May 24, 2007
Assessing the validity of self-reported medication adherence in hepatitis C treatmentScott R Smith, Abdus S Wahed, Stephanie S Kelley, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2014
Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potentialJulie C Lauffenburger, Christina L Mayer, Roy L Hawke, et al.
Journal of Clinical Gastroenterology|April 25, 2006
Social stigmatization and hepatitis C virus infectionSteven Zacks, Kimberly Beavers, Dickens Theodore, et al.
The Patient|November 25, 2016
What's Important to the Patient? Informational Needs of Patients Making Decisions About Hepatitis C TreatmentDonna M Evon, Carol E Golin, Teodora Stoica, et al.
Digestive Diseases and Sciences|March 31, 2007
High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbiditiesDonna M Evon, Amit Verma, Karen A Dougherty, et al.
Pageof 17